Back to Newsroom
Back to Newsroom

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 25, 2023 in Bausch Lawsuit – BHC

Tuesday, 15 August 2023 02:15 PM

Levi & Korsinsky, LLP

NEW YORK, NY / ACCESSWIRE / August 15, 2023 / Levi & Korsinsky, LLP notifies investors in Bausch Health Companies Inc. ("Bausch" or the "Company") (NYSE:BHC) of a class action securities lawsuit.

The lawsuit on behalf of Bausch investors has been commenced in the United States District Court for the District of New Jersey. Affected investors purchased or otherwise acquired certain Bausch Health Companies Inc. securities between August 6, 2020 and May 3, 2023. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/bausch-health-lawsuit-submission-form?prid=43585&wire=1

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500. There is no cost or obligation to you.

Bausch Health Companies Inc. NEWS - BHC NEWS

CASE DETAILS: The complaint alleges that defendants made false and/or misleading statements about the Company's spinoff of the Bausch + Lomb Corporation ("B+L"), including the benefits it would provide for Bausch shareholders and the effects it would have on Bausch post-spinoff. The complaint also alleges that the spinoff was done not to benefit shareholders but instead to undermine plaintiff lawsuits stemming from securities laws violations in 2016. Defendants' statements about the B+L spinoff have caused significant damages for Bausch investors. On August 6, 2020, when the spinoff was announced, Bausch's stock closed at $20.13 per share. The stock traded as high as $34.38 per share before falling to its current trading prices of under $10 per share.

WHAT THIS MEANS TO SHAREHOLDERS: If you suffered a loss in Bausch during the relevant timeframe, you have until September 25, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. Discuss your rights with our legal team without cost or obligation.

PROTECT YOUR FINANCIAL INTERESTS: Complete this brief submission form https://zlk.com/pslra-1/bausch-health-lawsuit-submission-form?prid=43585&wire=1 or call 212-363-7500 to discuss the case.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 4th Floor Suite #427
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

Topic:
Class Action
Back to newsroom
Back to Newsroom

Contact Us Today


If you have questions or want to learn more about our products, our team’s here to help!

Share by: